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t(2;11)(q37;q23) by G-banding and FISH with dual-color, break-apart MLL probe; Cecilia, Manuel R Teixeira (left); partial GTG-banded 
karyotype of t(2;11)(q37;23) and FISH analysis using probe LSI MLL DCBA demonstrating a 11q23 MLL rearrangement with a fusion 
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Clinics and pathology 
Disease 
Rare type of acute non lymphocytic leukemia (ANLL) 
and therapy-related ANLL. 
Phenotype / cell stem origin 
No specific AML FAB sub-type (two cases M4, one 
M2, one M5a and one NOS). 
Etiology 
Either de novo or therapy-related (prior cancer is 
variable: breast cancer, non-Hodgkin lymphoma and 
LLA). 
Epidemiology 
Five cases known in the literature; four adults ando e 
child, sex ratio 2M/3F; (age range 14.4-76). 
Prognosis 
Two cases showed poor survival, 9 and 17 months 
respectively, one case achieved remission after stem 
cell transplantation. The prognosis may be likely to be 
comparable with that of other entities with 11q23/MLL 
involvement, and worse in therapy related leukemias. 




The SEPT2 gene has 14 exons. 
SEPT2 has four types of transcripts with 3.6 kb, 3.5 kb, 
3.4 kb and 3.3 kb encoding the same protein, as a re ult 
of alternative splicing. 
Protein 
SEPT2 belongs to an evolutionarily conserved family 
of genes that encode a P loop-based GTP-binding 
domain flanked by a polybasic domain and (usually) a 
coiled-coil region, and assemble into homo- and hetero-
oligomers and filaments with key roles in cell divis on 
cytoskeletal dynamics and secretion. The SEPT2 gene
codes for a protein with 361 amino acids and a 
molecular weight of 41.5 kDa. 
SEPT2 was identified as a gene expressed in early 
embryonic mouse brain and down-regulated during 
development. It is ubiquitously expressed in cell lines 
and tissues with the highest protein levels found i 
brain tissue. 
The SEPT2 protein, like other septin family members, 
is thought to be cytoplasmic. SEPT2 co-localises with 
actin filaments in interphase cells, and in dividing cells 
concentrates at the cleavage furrow. 
SEPT2 is a multifunctional protein that was shown to 
be required for cytokinesis and to bind actin and 
associate with focal adhesions. Recent data support the 
idea that SEPT2 can have a role in chromosome 
congression and segregation. Additional functions have 
also been suggested; for instance, in rat brain lysates 
SEPT2 is part of a multi-septin complex that interacts 
with the exocyst complex, which plays a role in 
secretion and neurite outgrowth. SEPT2 has also been
localised to senile plaques of brains in patients with 
Alzheimer’s disease suggesting a role in 
neurodegeneration. 
The SEPT2 protein belongs to an evolutionarily family 
of proteins with at least 14 members and shares a very 




37 exons, spanning over 100 kb. 
In a centromeric to telomeric direction; 13 and 15 kb; 
coding sequence: 11.9 kb. 
Protein 
3969 amino acids; 431 kDa; contains from N-term to 
C-term 3 AT hooks homologous to high mobility group 
proteins HMGA1 and HMGA2, binding to the minor 
grove of DNA; 2 speckled nuclear localisation signals; 
2 repression domains RD1 and RD2: RD1 or CXXC: 
cystein methyl transferase, binds CpG rich DNA, has a  
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Structure of the normal MLL and SEPT2 proteins and the resulting MLL-SEPT2 fusion protein. 
transcriptional repression activity; RD2 recruits hi tone 
desacetylases HDAC1 and HDAC2; 3 plant 
homeodomains (cystein rich zinc finger domains, with 
homodimerization properties), 1 bromodomain (may 
bind acetylated histones), and 1 plant homeodomain; 
these domains may be involved in protein-protein 
interaction; a FYRN and a FRYC domain; a 
transactivation domain which binds CBP; may 
acetylates H3 and H4 in the HOX area; a SET domain: 
methyltransferase; methyltates H3, including histones 
in the HOX area for allowing chromatin to be open to 
transcription. MLL is cleaved by taspase 1 into 2 
proteins before entering the nucleus: a p300/320 N-
term protein called MLL-N, and a p180 C-term protein, 
called MLL-C. The FYRN and a FRYC domains of 
native MLL associate MLL-N and MLL-C in a stable 
complex; they form a multiprotein complex with 
transcription factor TFIID. 










AT hook, SNL-1, SNL-2 and DNA methyltransferase 
domains from MLL fused to almost the entire open-
reading frame of SEPT2, except for the first three 
aminoacids. 
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